Jagsonpal Pharmaceuticals Q2 FY27: PAT ₹13 & Rev ₹82

Metric	Value
Revenue	₹82
Net Profit (PAT)	₹13

📢 Key Event
Jagsonpal reports 9% revenue growth, 22% net profit growth, and completes Rs.40 crores share buyback

🔄 What Changed
22% net profit growth, Rs.40 crores buyback at 40% premium, Rs.170 crores cash balance post-buyback

🔮 What's Next
Target Rs.10 crores EBITDA from Aequitas within two years

💡 Investor Takeaway
Strong profit growth and cash position support expansion plans, but hospital segment margin pressures require monitoring

Jagsonpal Pharmaceuticals reported 9% revenue growth to Rs.82 crores and 22% net profit growth to Rs.13 crores in Q1 FY27, driven by strong operational performance and a 40% premium share buyback of Rs.40 crores. Gross margin improved to 65%+ with EBITDA at Rs.19 crores, while cash reserves stood at Rs.170 crores post-acquisition of Aequitas Healthcare for Rs.20.8 crores (85% stake). The company targets Rs.10 crores EBITDA from Aequitas within two years and plans organic growth through brand building and hospital cross-selling of key products like Maintane and Indocap.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JAGSNPHARM ✨ Ask AI About This

About Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,574.78 Cr P/E: 35.2 ROE: 19.0% ROCE: 25.8% Div Yield: 1.67%

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

💡 Ask AI about this filing

"How will Aequitas integration impact profitability by year two?" "What is the revenue contribution from top 10 products in Aequitas?" "When will hospital segment margins improve?"

Ask AI Free →

📊 More JAGSNPHARM filings

See all JAGSNPHARM filings →

🔥 Also filed on 4 August 2026

UNIMECH Unimech Aerospace and Manufacturing Limited Annual Report VRLLOG VRL Logistics Limited Financial Results PRICOLLTD Pricol Limited Financial Results EMAMILTD Emami Limited Financial Results WORTHPERI Worth Peripherals Limited Financial Results JYOTISTRUC Jyoti Structures Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JAGSNPHARM — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd